The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 6, Pages 628
Publisher
MDPI AG
Online
2019-06-21
DOI
10.3390/cells8060628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
- (2018) S. Kurnool et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
- (2018) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association of circulating resistin, leptin, adiponectin and visfatin levels with Behçet disease: a meta-analysis
- (2018) Y. H. Lee et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn’s Disease
- (2018) Weisong Shen et al. DISEASES OF THE COLON & RECTUM
- Hyperadiponectinemia During Infliximab Induction Therapy in Pediatric Crohn Disease
- (2018) Klara Frivolt et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- The human mesenteric lymph node microbiome differentiates between Crohn’s disease and ulcerative colitis
- (2018) Miranda G Kiernan et al. Journal of Crohns & Colitis
- OUP accepted manuscript
- (2018) Journal of Crohns & Colitis
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohnʼs Disease
- (2017) Kimberley W. J. Van Der Sloot et al. INFLAMMATORY BOWEL DISEASES
- Increase of Intra-abdominal Adipose Tissue in Pediatric Crohn Disease
- (2017) Klara Frivolt et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Association of retinol-binding protein 4 with metabolic syndrome in first-degree relatives of type 2 diabetic patients
- (2017) Maryam Zare et al. Journal of Research in Medical Sciences
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis
- (2017) Qiongyuan Hu et al. MEDICAL SCIENCE MONITOR
- Dynamics of the human gut microbiome in inflammatory bowel disease
- (2017) Jonas Halfvarson et al. Nature Microbiology
- Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables
- (2017) Michelle G. Swainson et al. PLoS One
- Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery
- (2016) Z. Ding et al. Colorectal Disease
- Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease
- (2016) Sotirios Terzoudis et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC
- (2016) Amanda E Starr et al. GUT
- Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases
- (2016) Eleni Theocharidou et al. INFLAMMATORY BOWEL DISEASES
- Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
- (2016) Silvia Speca et al. INFLAMMATORY BOWEL DISEASES
- The Role of the Mesentery in Crohnʼs Disease
- (2016) Yi Li et al. INFLAMMATORY BOWEL DISEASES
- Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005–2012
- (2016) A J Tomiyama et al. INTERNATIONAL JOURNAL OF OBESITY
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
- (2016) Isabelle Cleynen et al. LANCET
- Interaction of obesity and inflammatory bowel disease
- (2016) Jason W Harper et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis
- (2016) Y. H. Lee et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease
- (2016) Darcy Q Holt et al. Clinical and Translational Gastroenterology
- Leptin Deficiency
- (2016) Susan Blüher et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
- (2015) Piotr Eder et al. ABDOMINAL IMAGING
- Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease
- (2015) Avegail Flores et al. DIGESTIVE DISEASES AND SCIENCES
- Measures of Obesity and Risk of Crohnʼs Disease and Ulcerative Colitis
- (2015) Hamed Khalili et al. INFLAMMATORY BOWEL DISEASES
- Visceral Adipose Tissue in Patients with Crohnʼs Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome
- (2015) Carsten Büning et al. INFLAMMATORY BOWEL DISEASES
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
- (2015) Deepak Sampath et al. PHARMACOLOGY & THERAPEUTICS
- From next-generation sequencing to systematic modeling of the gut microbiome
- (2015) Boyang Ji et al. Frontiers in Genetics
- Obesity in autoimmune diseases: Not a passive bystander
- (2014) Mathilde Versini et al. AUTOIMMUNITY REVIEWS
- Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization
- (2014) Yuli Lin et al. Cellular & Molecular Immunology
- Role of fat and adipokines in intestinal inflammation
- (2014) LeaI Kredel et al. CURRENT OPINION IN GASTROENTEROLOGY
- Volumetric Fat Ratio and Not Body Mass Index Is Predictive of Ileocolectomy Outcomes in Crohn's Disease Patients
- (2014) Tara M. Connelly et al. DIGESTIVE SURGERY
- Serum Omentin-1 as a Disease Activity Marker for Crohn’s Disease
- (2014) Yan Lu et al. DISEASE MARKERS
- Chemerin/chemR23 axis in inflammation onset and resolution
- (2014) Francesco Mariani et al. INFLAMMATION RESEARCH
- Impact of Abdominal Visceral Adipose Tissue on Disease Outcome in Pediatric Crohnʼs Disease
- (2014) Victor Uko et al. INFLAMMATORY BOWEL DISEASES
- Influence of Exclusive Enteral Nutrition Therapy on Visceral Fat in Patients with Crohnʼs Disease
- (2014) Yi Li et al. INFLAMMATORY BOWEL DISEASES
- Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes
- (2014) T. Stroh et al. JOURNAL OF IMMUNOLOGY
- Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131
- (2014) Lex Van der Ploeg et al. LIFE SCIENCES
- PPARγ and the global map of adipogenesis and beyond
- (2014) Martina I. Lefterova et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Serum adipokines in inflammatory bowel disease
- (2014) Marek Waluga WORLD JOURNAL OF GASTROENTEROLOGY
- Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study)
- (2013) Simon S M Chan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus
- (2013) Andrea Shin et al. Clinical Gastroenterology and Hepatology
- New therapeutic avenues in ulcerative colitis: thinking out of the box
- (2013) Joana Torres et al. GUT
- The Increasing Weight of Crohnʼs Disease Subjects in Clinical Trials
- (2013) Gordon W. Moran et al. INFLAMMATORY BOWEL DISEASES
- Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitis
- (2013) Giorgos Chouliaras et al. PEDIATRIC RESEARCH
- Differences in Visceral Fat and Fat Bacterial Colonization between Ulcerative Colitis and Crohn’s Disease. An In Vivo and In Vitro Study
- (2013) Alessandra Zulian et al. PLoS One
- Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease
- (2012) V. S. Rodrigues et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- NOD1 activation induces innate immune responses and insulin resistance in human adipocytes
- (2012) Y.-J. Zhou et al. DIABETES & METABOLISM
- Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease
- (2012) Lea Isabell Kredel et al. GUT
- Adipose Tissue and Inflammatory Bowel Disease Pathogenesis
- (2012) Christopher Fink et al. INFLAMMATORY BOWEL DISEASES
- High prevalence of overweight and obesity in adults with Crohn's disease: Associations with disease and lifestyle factors
- (2012) Treasa Nic Suibhne et al. Journal of Crohns & Colitis
- Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
- (2012) Céline Pirat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mesenteric fat—control site for bacterial translocation in colitis?
- (2012) A Batra et al. Mucosal Immunology
- Interactions Between the Microbiota and the Immune System
- (2012) L. V. Hooper et al. SCIENCE
- PPARγin Inflammatory Bowel Disease
- (2012) Vito Annese et al. PPAR Research
- Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells
- (2011) Hideyuki Yamawaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease
- (2011) Bara Erhayiem et al. Clinical Gastroenterology and Hepatology
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
- (2011) Alessandra Zulian et al. GUT
- Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
- (2011) L. Puig JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Resistin is Associated with Breach of Tolerance and Anti-nuclear Antibodies in Patients with Hepatobiliary Inflammation
- (2011) E. A. Boström et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
- (2010) R. DUCHMANN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Revisiting the Rosiglitazone Story — Lessons Learned
- (2010) Clifford J. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland
- (2010) Helen Steed et al. Obesity Facts
- Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
- (2010) L. Peyrin-Biroulet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apoptosis and Inflammation: Role of Adipokines in Inflammatory Bowel Disease
- (2010) Venkatesh Ponemone et al. Clinical and Translational Gastroenterology
- Leptin: A Critical Regulator of CD4+T-cell Polarizationin Vitroandin Vivo
- (2009) Arvind Batra et al. ENDOCRINOLOGY
- Adipokine signaling in inflammatory bowel disease
- (2009) A. Batra et al. INFLAMMATORY BOWEL DISEASES
- Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohnʼs disease
- (2009) Johanna Weigert et al. INFLAMMATORY BOWEL DISEASES
- The relationship of visfatin/pre–B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids
- (2009) Yi-Cheng Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate Immunity and Adipocyte Function: Ligand-specific Activation of Multiple Toll-like Receptors Modulates Cytokine, Adipokine, and Chemokine Secretion in Adipocytes
- (2009) Andrea Kopp et al. Obesity
- Subcutaneous and visceral adipose tissue: structural and functional differences
- (2009) M. Mohsen Ibrahim Obesity Reviews
- Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
- (2009) Seung Hwan Han et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
- (2008) James D. Lewis et al. GASTROENTEROLOGY
- Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signalling with innate immunity
- (2008) Andreas Schaeffler et al. IMMUNOLOGY
- Indeterminate colitis: A review of the concept — Whatʼs in a name?
- (2008) Karel Geboes et al. INFLAMMATORY BOWEL DISEASES
- Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohnʼs disease
- (2008) Shuhei Hosomi et al. INFLAMMATORY BOWEL DISEASES
- Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohnʼs disease
- (2008) Giovanni Maconi et al. INFLAMMATORY BOWEL DISEASES
- BMI-related errors in the measurement of obesity
- (2008) K J Rothman INTERNATIONAL JOURNAL OF OBESITY
- Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
- (2008) T. Luk et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease
- (2008) Luzia Valentini et al. NUTRITION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started